Related references
Note: Only part of the references are listed.Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (II) A Randomized Trial with IL-5 Antagonists
Victoria Gershuny et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)
Evaluating the Utility of Proteomics for the Identification of Circulating Pharmacodynamic Biomarkers of IFNβ-1a Biologics
Paula L. L. Hyland et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)
Pharmacodynamic Biomarkers Evidentiary Considerations for Biosimilar Development and Approval
David G. Strauss et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (I) A Randomized Trial with PCSK9 Inhibitors
Morasa Sheikhy et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (III) A Randomized Trial with Interferon Beta-1a Products
Jeffry Florian et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)
Pharmacodynamic Biomarkers for Biosimilar Development and Approval: A Workshop Summary
Jeffry Florian et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)
In Vitro Testing of Sunscreens for Dermal Absorption: Method Comparison and Rank Order Correlation with In Vivo Absorption
Yang Yang et al.
AAPS PHARMSCITECH (2022)
Expanding Approved Patient Populations for Rare Disease Treatment Using In Vitro Data
James L. Weaver et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
Calibration and Validation of a Mechanistic COVID-19 Model for Translational Quantitative Systems Pharmacology-A Proof-of-Concept Model Development for Remdesivir
Mohammadreza Samieegohar et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
Development of a Translational Model to Assess the Impact of Opioid Overdose and Naloxone Dosing on Respiratory Depression and Cardiac Arrest
John Mann et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
Analysis of secondary pharmacology assays received by the US Food and Drug Administration
Christina Scott et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2022)
Effect of Paroxetine or Quetiapine Combined With Oxycodone vs Oxycodone Alone on Ventilation During Hypercapnia A Randomized Clinical Trial
Jeffry Florian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Development of QSAR models to predict blood-brain barrier permeability
Sadegh Faramarzi et al.
FRONTIERS IN PHARMACOLOGY (2022)
Target Adverse Event Profiles for Predictive Safety in the Postmarket Setting
Peter Schotland et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Microengineered systems with iPSC-derived cardiac and hepatic cells to evaluate drug adverse effects
Keri Dame et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2021)
Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation
Andres Rubiano et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)
Assessing the impact of expert knowledge on ICH M7 (Q)SAR predictions. Is expert review still needed?
P. Suresh Jayasekara et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2021)
How μ-opioid receptor recognizes fentanyl
Quynh N. Vo et al.
NATURE COMMUNICATIONS (2021)
Emergence of nosocomial associated opportunistic pathogens in the gut microbiome after antibiotic treatment
Isaac Raplee et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2021)
Novel simultaneous method for the determination of avobenzone and oxybenzone in human plasma by UHPLC-MS/MS with phospholipid removal pretreatment: An application to a sunscreen clinical trial
Nageswara R. Pilli et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2021)
Effects of sedative psychotropic drugs combined with oxycodone on respiratory depression in the rat
Lin Xu et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)
Effect of Oral Ranitidine on Urinary Excretion of N-Nitrosodimethylamine (NDMA) A Randomized Clinical Trial
Jeffry Florian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Implementation of the principles of the 3Rs of animal testing at CDER: Past, present and future
Ronald L. Wange et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2021)
Simultaneous quantification of dexamethasone and 6β-hydroxydexamethasone in rabbit plasma, aqueous and vitreous humor, and retina by UHPLC-MS/MS
Jianghong Gu et al.
BIOANALYSIS (2021)
Aggregation and analysis of secondary pharmacology data from investigational new drug submissions at the US Food and Drug Administration
Andrew Dodson et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2021)
Characterization of a commercially available line of iPSC hepatocytes as models of hepatocyte function and toxicity for regulatory purposes
Hisham Qosa et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2021)
In Vitro Analysis of N-Nitrosodimethylamine (NDMA) Formation From Ranitidine Under Simulated Gastrointestinal Conditions
Zongming Gao et al.
JAMA NETWORK OPEN (2021)
Kinetics and Mechanism of Fentanyl Dissociation from the μ-Opioid Receptor
Paween Mahinthichaichan et al.
JACS AU (2021)
Advancing Biosimilar Development Using Pharmacodynamic Biomarkers in Clinical Pharmacology Studies
Junyi Li et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy
Zhihua Li et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Effect of drug combinations on the kinetics of antibiotic resistance emergence in Escherichia coli CFT073 using an in vitro hollow-fibre infection model
Narayana Garimella et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients A Randomized Clinical Trial
Murali K. Matta et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Evaluating kratom alkaloids using PHASE
Christopher R. Ellis et al.
PLOS ONE (2020)
Predicting potential adverse events using safety data from marketed drugs
Chathuri Daluwatte et al.
BMC BIOINFORMATICS (2020)
Cross-site and cross-platform variability of automated patch clamp assessments of drug effects on human cardiac currents in recombinant cells
James Kramer et al.
SCIENTIFIC REPORTS (2020)
Development of improved QSAR models for predicting the outcome of the in vivo micronucleus genetic toxicity assay
Jae Wook Yoo et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs)
Amy M. Avila et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
A general procedure to select calibration drugs for lab-specific validation and calibration of proarrhythmia risk prediction models: An illustrative example using the CiPA model
Xiaomei Han et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2020)
Quantifying drug-induced structural toxicity in hepatocytes and cardiomyocytes derived from hiPSCs using a deep learning method
Mahnaz Maddah et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2020)
Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the CiPA Initiative
Zhihua Li et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
The Potential Role of the J-Tpeak Interval in Proarrhythmic Cardiac Safety: Current State of the Science From the American College of Clinical Pharmacology and the Cardiac Safety Research Consortium
Jose Vicente et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
BLT-Immune Humanized Mice as a Model for Nivolumab-Induced Immune-Mediated Adverse Events: Comparison of the NOG and NOG-EXL Strains
James L. Weaver et al.
TOXICOLOGICAL SCIENCES (2019)
Evaluation of a TGN1412 analogue using in vitro assays and two immune humanized mouse models
Hangyi Yan et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)
Assessing the Structural and Pharmacological Similarity of Newly Identified Drugs of Abuse to Controlled Substances Using Public Health Assessment via Structural Evaluation
Christopher R. Ellis et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Liver Microphysiological Systems for Predicting and Evaluating Drug Effects
Alexandre J. S. Ribeiro et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients A Randomized Clinical Trial
Murali K. Matta et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Drug-Drug Interaction Studies of Methadone and Antiviral Drugs: Lessons Learned
Islam R. Younis et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Bone marrow-liver-thymus (BLT) immune humanized mice as a model to predict cytokine release syndrome
Hangyi Yan et al.
TRANSLATIONAL RESEARCH (2019)
Use of pharmacodynamic/response biomarkers for therapeutic biologics regulatory submissions
Yow-Ming C. Wang et al.
BIOMARKERS IN MEDICINE (2019)
Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Adverse Drug-Induced Inotropic Effects in Early Drug Development. Part 1: General Considerations for Development of Novel Testing Platforms
Brian D. Guth et al.
FRONTIERS IN PHARMACOLOGY (2019)
Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Drug-Induced Inotropic Effects in Early Drug Development. Part 2: Designing and Fabricating Microsystems for Assaying Cardiac Contractility With Physiological Relevance Using Human iPSC-Cardiomyocytes
Alexandre J. S. Ribeiro et al.
FRONTIERS IN PHARMACOLOGY (2019)
Comprehensive In Vitro Proarrhythmia Assay (CiPA) Update from a Cardiac Safety Research Consortium / Health and Environmental Sciences Institute / FDA Meeting
David G. Strauss et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2019)
Drug potency on inhibiting late Na+ current is sensitive to gating modifier and current region where drug effects were measured
Min Wu et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2019)
Assessment of Multi-Ion Channel Block in a Phase I Randomized Study Design: Results of the CiPA Phase I ECG Biomarker Validation Study
Jose Vicente et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Transitioning to composite bacterial mutagenicity models in ICH M7 (Q)SAR analyses
Curran Landry et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2019)
Translating New Science Into the Drug Review Process: The US FDA's Division of Applied Regulatory Science
Rodney Rouse et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2018)
Cross-Site Reliability of Human Induced Pluripotent stem cell-derived Cardiomyocyte Based Safety Assays Using Microelectrode Arrays: Results from a Blinded CiPA Pilot Study
Daniel Millard et al.
TOXICOLOGICAL SCIENCES (2018)
Novel and rapid LC-MS/MS method for quantitative analysis of methylphenidate in dried blood spots
Adarsh Gandhi et al.
BIOANALYSIS (2018)
Methadone Metabolism and Drug-Drug Interactions: In Vitro and In Vivo Literature Review
Donna A. Volpe et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception
Rebecca Zash et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Construction and application of (Q)SAR models to predict chemical-induced in vitro chromosome aberrations
Chia-Wen Hsu et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2018)
International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment
Ksenia Blinova et al.
CELL REPORTS (2018)
Target-Adverse Event Profiles to Augment Pharmacovigilance: A Pilot Study With Six New Molecular Entities
Peter Schotland et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2018)
Mechanistic Model-Informed Proarrhythmic Risk Assessment of Drugs: Review of the CiPA Initiative and Design of a Prospective Clinical Validation Study
Jose Vicente et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Naloxone dosage for opioid reversal: current evidence and clinical implications
Rachael Rzasa Lynn et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2018)
The ChEMBL database in 2017
Anna Gaulton et al.
NUCLEIC ACIDS RESEARCH (2017)
Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias
Ksenia Blinova et al.
TOXICOLOGICAL SCIENCES (2017)
Uncertainty Quantification Reveals the Importance of Data Variability and Experimental Design Considerations for in Silico Proarrhythmia Risk Assessment
Kelly C. Chang et al.
FRONTIERS IN PHYSIOLOGY (2017)
Optimization of an In silico Cardiac Cell Model for Proarrhythmia Risk Assessment
Sara Dutta et al.
FRONTIERS IN PHYSIOLOGY (2017)
Improving the In Silico Assessment of Proarrhythmia Risk by Combining hERG (Human Ether-a-go-go-Related Gene) Channel-Drug Binding Kinetics and Multichannel Pharmacology
Zhihua Li et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2017)
Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial
L. Johannesen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
A Proactive Response to Prescription Opioid Abuse
Robert M. Califf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses
Alexander Amberg et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2016)
An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel
William J. Crumb et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2016)
The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative Update on progress
Thomas Colatsky et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2016)
Automated Algorithm for J-Tpeak and Tpeak-Tend Assessment of Drug-Induced Proarrhythmia Risk
Lars Johannesen et al.
PLOS ONE (2016)
Sex differences in drug-induced changes in ventricular repolarization
Jose Vicente et al.
JOURNAL OF ELECTROCARDIOLOGY (2015)
Establishing best practise in the application of expert review of mutagenicity under ICH M7
Chris Barber et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2015)
Comprehensive T wave Morphology Assessment in a Randomized Clinical Study of Dofetilide, Quinidine, Ranolazine, and Verapamil
Jose Vicente et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Improving the Assessment of Heart Toxicity for All New Drugs Through Translational Regulatory Science
L. Johannesen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Differentiating Drug-Induced Multichannel Block on the Electrocardiogram: Randomized Study of Dofetilide, Quinidine, Ranolazine, and Verapamil
L. Johannesen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
(Q)SAR Modelling and Safety Assessment in Regulatory Review
N. L. Kruhlak et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)